These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1420054)

  • 1. Vitreon, a short-term vitreoretinal tamponade.
    Blinder KJ; Peyman GA; Desai UR; Nelson NC; Alturki W; Paris CL
    Br J Ophthalmol; 1992 Sep; 76(9):525-8. PubMed ID: 1420054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study.
    Verma LK; Peyman GA; Wafapoor H; Greve MD; Millsap CM; Adile SL
    Ophthalmic Surg; 1995; 26(1):29-33. PubMed ID: 7746621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroperhydrophenanthrene (Vitreon) as a short-term vitreous substitute after complex vitreoretinal surgery.
    Tanji TM; Peyman GA; Mehta NJ; Millsap CM
    Ophthalmic Surg; 1993 Oct; 24(10):681-5. PubMed ID: 8259246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early posterior capsule fibrosis after combined cataract and vitreoretinal surgery with intraocular air/SF6 gas tamponade].
    Scharwey K; Pavlovic S; Jacobi KW
    Klin Monbl Augenheilkd; 1998 Mar; 212(3):149-53. PubMed ID: 9592739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreon, a new perfluorocarbon.
    Blinder KJ; Peyman GA; Paris CL; Dailey JP; Alturki W; Lui KR; Gremillion CM; Clark LC
    Br J Ophthalmol; 1991 Apr; 75(4):240-4. PubMed ID: 2021595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group.
    Carroll BF; Peyman GA; Mehta NJ; Millsap CM; Greve MD; Dunlap WA; Lee KJ; Ma PE
    Can J Ophthalmol; 1994 Apr; 29(2):66-9. PubMed ID: 8069756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative complications of perfluoroperhydrophenanthrene: subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon. Vitreon Study Group.
    Meffert S; Peyman GA
    Can J Ophthalmol; 1999 Aug; 34(5):272-80. PubMed ID: 10486686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study.
    Millsap CM; Peyman GA; Mehta NJ; Greve MD; Lee KJ; Ma PE; Dunlap WA
    Ophthalmic Surg; 1993 Nov; 24(11):759-63. PubMed ID: 8290216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon).
    Schulman JA; Peyman GA; Blinder KJ; Alturki WA; Desai UR; Nelson NC
    Jpn J Ophthalmol; 1993; 37(1):70-7. PubMed ID: 8320868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy.
    Chang S; Ozmert E; Zimmerman NJ
    Am J Ophthalmol; 1988 Dec; 106(6):668-74. PubMed ID: 3195646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
    Khan MA; Shahlaee A; Toussaint B; Hsu J; Sivalingam A; Dugel PU; Lakhanpal RR; Riemann CD; Berrocal MH; Regillo CD; Ho AC
    Am J Ophthalmol; 2016 Jan; 161():36-43.e1-2. PubMed ID: 26429584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Term Vitreoretinal Tamponade with Heavy Liquid Following Surgery for Giant Retinal Tear.
    Eiger-Moscovich M; Gershoni A; Axer-Siegel R; Weinberger D; Ehrlich R
    Curr Eye Res; 2017 Jul; 42(7):1074-1078. PubMed ID: 28157410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
    Loewenstein A; Humayun MS; de Juan E; Campochiaro PA; Haller JA
    Ophthalmology; 2000 Jun; 107(6):1078-82. PubMed ID: 10857826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorocarbon liquids (perfluorodecalin) in vitreoretinal surgery--a local experience.
    Ong SG; Heng LK; Tan BB; Ang CL; Ang BC
    Ann Acad Med Singap; 1993 May; 22(3):348-50. PubMed ID: 8373117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated fluid-gas exchange for hypotony after vitreoretinal surgery for proliferative vitreoretinopathy.
    Stallman JB; Meyers SM
    Am J Ophthalmol; 1988 Aug; 106(2):147-53. PubMed ID: 3400756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair.
    Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC
    Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome after vitrectomy in rhegmatogenous retinal detachment and dense vitreous opacities].
    Hoerauf H; Roider J; Herboth T; Hager A; Laqua H
    Klin Monbl Augenheilkd; 1997 Dec; 211(6):369-74. PubMed ID: 9498187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relaxing retinopathies and liquid perfluorocarbons].
    Morel C; Doan S; Rivoal O; Ameline B; Monin C; Larricart P
    J Fr Ophtalmol; 1998 May; 21(5):315-20. PubMed ID: 9759424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended retinal tamponade in the treatment of retinal detachment with proliferative vitreoretinopathy.
    Stern WH; Johnson RN; Irvine AR; Barricks ME; Boyden BS; Hilton GF; Lonn LI; Schwartz A
    Br J Ophthalmol; 1986 Dec; 70(12):911-7. PubMed ID: 3801368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of simultaneous internal tamponade on fluid compartmentalization and its relationship to cell proliferation.
    De Molfetta V; Bottoni F; Arpa P; Vinciguerra P; Zenoni S
    Retina; 1992; 12(3 Suppl):S40-5. PubMed ID: 1455082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.